Medtronic PLC
MDT98.660USD
-1.210-1.21%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
126.48BMarktkapitalisierung
26.55KGV TTM
mehr Informationen über Medtronic PLC Unternehmen
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Medtronic PLC Informationen
BörsenkürzelMDT
Name des UnternehmensMedtronic PLC
IPO-datumNov 21, 1977
CEOMartha (Geoffrey S)
Anzahl der mitarbeiter95000
WertpapierartOrdinary Share
GeschäftsjahresendeNov 21
AddresseBuilding Two Parkmore Business Park West
StadtDUBLIN
BörseNASDAQ OMX NASDAQ Basic NYSE
LandIreland
PostleitzahlH91 4K49
Telefon1135314381700
Websitehttps://www.medtronic.com/
BörsenkürzelMDT
IPO-datumNov 21, 1977
CEOMartha (Geoffrey S)
Führungskräfte von Medtronic PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.71K
+0.89%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
17.64K
+0.41%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
8.19K
+0.89%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.39K
-81.26%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
Andere
2.41B
28.11%
Nach RegionUSD
Name
Umsatz
Anteil
Rest of World
4.32B
50.37%
United States
4.22B
49.24%
Ireland
33.00M
0.38%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
Andere
2.41B
28.11%
Aktionärsstatistik
Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
Andere
74.57%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
Andere
74.57%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
46.90%
Investment Advisor/Hedge Fund
29.42%
Research Firm
4.18%
Pension Fund
2.40%
Bank and Trust
2.17%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.37%
Insurance Company
0.38%
Individual Investor
0.28%
Andere
11.49%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
3723
1.13B
88.20%
-2.77M
2025Q2
3762
1.12B
87.12%
-18.03M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
126.32M
9.85%
+1.88M
+1.51%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
67.84M
5.29%
-1.09M
-1.58%
Jun 30, 2025
State Street Investment Management (US)
59.83M
4.66%
-210.22K
-0.35%
Jun 30, 2025
JP Morgan Asset Management
26.31M
2.05%
-1.69M
-6.03%
Jun 30, 2025
Capital Research Global Investors
36.36M
2.83%
-5.21M
-12.53%
Jun 30, 2025
Geode Capital Management, L.L.C.
28.23M
2.2%
+310.68K
+1.11%
Jun 30, 2025
MFS Investment Management
19.36M
1.51%
-1.24M
-6.04%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
16.44M
1.28%
+1.87M
+12.83%
Jun 30, 2025
Managed Account Advisors LLC
13.77M
1.07%
-170.61K
-1.22%
Jun 30, 2025
BlackRock Financial Management, Inc.
15.63M
1.22%
+1.48M
+10.48%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Absolute Select Value ETF
4.89%
iShares U.S. Medical Devices ETF
4.4%
iShares Health Innovation Active ETF
4.26%
Cullen Enhanced Equity Income ETF
4.24%
USCF Dividend Income Fund
3.59%
JPMorgan Healthcare Leaders ETF
3.22%
Madison Dividend Value ETF
3.08%
Tema Heart & Health ETF
2.98%
Global X Aging Population ETF
2.98%
WisdomTree US AI Enhanced Value Fund
2.86%
Mehr Anzeigen
Absolute Select Value ETF
Anteil4.89%
iShares U.S. Medical Devices ETF
Anteil4.4%
iShares Health Innovation Active ETF
Anteil4.26%
Cullen Enhanced Equity Income ETF
Anteil4.24%
USCF Dividend Income Fund
Anteil3.59%
JPMorgan Healthcare Leaders ETF
Anteil3.22%
Madison Dividend Value ETF
Anteil3.08%
Tema Heart & Health ETF
Anteil2.98%
Global X Aging Population ETF
Anteil2.98%
WisdomTree US AI Enhanced Value Fund
Anteil2.86%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
17.37B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Aug 14, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option
Sep 26, 2025
Oct 17, 2025
Sep 26, 2025
May 21, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Medtronic PLC?
Die fünf größten Anteilseigner von Medtronic PLC sind:
The Vanguard Group, Inc. hält 126.32M Aktien, was 9.85% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 67.84M Aktien, was 5.29% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 59.83M Aktien, was 4.66% der Gesamtaktien entspricht.
JP Morgan Asset Management hält 26.31M Aktien, was 2.05% der Gesamtaktien entspricht.
Capital Research Global Investors hält 36.36M Aktien, was 2.83% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 126.32M Aktien, was 9.85% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 67.84M Aktien, was 5.29% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 59.83M Aktien, was 4.66% der Gesamtaktien entspricht.
JP Morgan Asset Management hält 26.31M Aktien, was 2.05% der Gesamtaktien entspricht.
Capital Research Global Investors hält 36.36M Aktien, was 2.83% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Medtronic PLC?
Die drei wichtigsten Anteilseigner-Typen von Medtronic PLC sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an Medtronic PLC (MDT)?
Mit Stand vom 2025Q3 halten 3723 Institutionen Anteile an Medtronic PLC, mit einem Gesamtmarktwert von etwa 1.13B, was 88.20% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um 1.08% gestiegen.
Was ist die größte Einnahmequelle von Medtronic PLC?
Am FY2026Q1 erzielte das Geschäft mit Cardiac Rhythm & Heart Failure für Medtronic PLC den höchsten Umsatz in Höhe von 1.71B, was 19.96% des Gesamtumsatzes entspricht.
